Zygolide ® is a first-to-market generic, peppermint-flavored pergolide tablet, offering enhanced features for horses suffering from Pituitary Pars Intermedia Dysfunction OVERLAND PARK, Kan., January ...
Dechra, a global leader in veterinary specialty care, today announced the FDA approval of Zygolide ® (pergolide tablets), the first FDA-approved bioequivalent option indicated for the control of ...
Dechra Announces FDA Approval of Zygolide® (pergolide tablets) for the Control of Clinical Signs Associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in Horses Zygolide® is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results